Annual Operating Profit
$33.27 M
+$2.54 M+8.28%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual operating income is $33.27 million, with the most recent change of +$2.54 million (+8.28%) on December 31, 2023.
- During the last 3 years, PBYI annual operating profit has risen by +$63.67 million (+209.42%).
- PBYI annual operating profit is now at all-time high.
Performance
PBYI Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$22.08 M
+$24.26 M+1113.26%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly operating income is $22.08 million, with the most recent change of +$24.26 million (+1113.26%) on September 30, 2024.
- Over the past year, PBYI quarterly operating profit has increased by +$12.87 million (+139.73%).
- PBYI quarterly operating profit is now at all-time high.
Performance
PBYI Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$32.40 M
+$12.87 M+65.89%
September 30, 2024
Summary
- As of February 7, 2025, PBYI TTM operating income is $32.40 million, with the most recent change of +$12.87 million (+65.89%) on September 30, 2024.
- Over the past year, PBYI TTM operating profit has increased by +$3.92 million (+13.75%).
- PBYI TTM operating profit is now -9.58% below its all-time high of $35.83 million, reached on March 31, 2023.
Performance
PBYI TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
PBYI Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +8.3% | +139.7% | +13.8% |
3 y3 years | +209.4% | +83.1% | +252.6% |
5 y5 years | +135.1% | +83.1% | +252.6% |
PBYI Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +2478.7% | at high | +1060.4% | -9.6% | +266.1% |
5 y | 5-year | at high | +185.2% | at high | +232.7% | -9.6% | +151.3% |
alltime | all time | at high | +111.4% | at high | +128.2% | -9.6% | +110.7% |
Puma Biotechnology Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $22.08 M(-1113.3%) | $32.40 M(+65.9%) |
Jun 2024 | - | -$2.18 M(-5.2%) | $19.53 M(-26.6%) |
Mar 2024 | - | -$2.30 M(-115.5%) | $26.60 M(-20.0%) |
Dec 2023 | $33.27 M(+8.3%) | $14.80 M(+60.7%) | $33.27 M(+16.8%) |
Sep 2023 | - | $9.21 M(+88.3%) | $28.48 M(-0.6%) |
Jun 2023 | - | $4.89 M(+12.1%) | $28.67 M(-20.0%) |
Mar 2023 | - | $4.37 M(-56.4%) | $35.83 M(+16.6%) |
Dec 2022 | $30.72 M(+2281.4%) | $10.02 M(+6.6%) | $30.72 M(+11.6%) |
Sep 2022 | - | $9.39 M(-22.1%) | $27.54 M(+199.7%) |
Jun 2022 | - | $12.06 M(-1714.2%) | $9.19 M(-147.1%) |
Mar 2022 | - | -$747.00 K(-110.9%) | -$19.50 M(-1502.0%) |
Dec 2021 | $1.29 M(-104.2%) | $6.83 M(-176.3%) | $1.39 M(-108.4%) |
Sep 2021 | - | -$8.95 M(-46.2%) | -$16.59 M(-16.1%) |
Jun 2021 | - | -$16.63 M(-182.6%) | -$19.77 M(-594.8%) |
Mar 2021 | - | $20.15 M(-280.7%) | $4.00 M(-113.1%) |
Dec 2020 | -$30.40 M(-22.1%) | -$11.15 M(-8.1%) | -$30.40 M(+8.9%) |
Sep 2020 | - | -$12.13 M(-270.2%) | -$27.92 M(-7.7%) |
Jun 2020 | - | $7.13 M(-150.0%) | -$30.23 M(-52.1%) |
Mar 2020 | - | -$14.25 M(+64.5%) | -$63.14 M(+61.7%) |
Dec 2019 | -$39.05 M(-58.8%) | -$8.66 M(-40.0%) | -$39.05 M(-20.2%) |
Sep 2019 | - | -$14.45 M(-44.0%) | -$48.92 M(+6.9%) |
Jun 2019 | - | -$25.78 M(-361.8%) | -$45.75 M(-25.5%) |
Mar 2019 | - | $9.85 M(-153.1%) | -$61.41 M(-35.1%) |
Dec 2018 | -$94.66 M(-67.6%) | -$18.54 M(+64.3%) | -$94.66 M(-32.2%) |
Sep 2018 | - | -$11.28 M(-72.8%) | -$139.69 M(-32.1%) |
Jun 2018 | - | -$41.44 M(+77.2%) | -$205.84 M(-15.1%) |
Mar 2018 | - | -$23.39 M(-63.2%) | -$242.58 M(-17.0%) |
Dec 2017 | -$292.39 M(+5.7%) | -$63.57 M(-17.9%) | -$292.39 M(-3.1%) |
Sep 2017 | - | -$77.44 M(-0.9%) | -$301.69 M(+3.9%) |
Jun 2017 | - | -$78.18 M(+6.8%) | -$290.25 M(+4.2%) |
Mar 2017 | - | -$73.20 M(+0.5%) | -$278.55 M(+0.7%) |
Dec 2016 | -$276.60 M | -$72.87 M(+10.4%) | -$276.60 M(+4.1%) |
Sep 2016 | - | -$66.00 M(-0.7%) | -$265.76 M(+2.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2016 | - | -$66.48 M(-6.7%) | -$260.50 M(+0.6%) |
Mar 2016 | - | -$71.25 M(+14.8%) | -$258.93 M(+7.8%) |
Dec 2015 | -$240.28 M(+68.9%) | -$62.03 M(+2.1%) | -$240.28 M(+6.4%) |
Sep 2015 | - | -$60.73 M(-6.4%) | -$225.84 M(+12.3%) |
Jun 2015 | - | -$64.91 M(+23.4%) | -$201.06 M(+14.9%) |
Mar 2015 | - | -$52.60 M(+10.5%) | -$175.06 M(+23.0%) |
Dec 2014 | -$142.28 M(+159.5%) | -$47.59 M(+32.4%) | -$142.28 M(+28.6%) |
Sep 2014 | - | -$35.96 M(-7.6%) | -$110.67 M(+24.3%) |
Jun 2014 | - | -$38.91 M(+96.3%) | -$89.04 M(+41.7%) |
Mar 2014 | - | -$19.82 M(+24.0%) | -$62.85 M(+14.6%) |
Dec 2013 | -$54.83 M(-26.3%) | -$15.99 M(+11.6%) | -$54.83 M(-9.8%) |
Sep 2013 | - | -$14.33 M(+12.8%) | -$60.79 M(-16.0%) |
Jun 2013 | - | -$12.71 M(+7.6%) | -$72.33 M(-2.8%) |
Mar 2013 | - | -$11.81 M(-46.2%) | -$74.40 M(-0.1%) |
Dec 2012 | -$74.45 M(+633.0%) | -$21.95 M(-15.2%) | -$74.45 M(+19.5%) |
Sep 2012 | - | -$25.87 M(+75.1%) | -$62.29 M(+69.5%) |
Jun 2012 | - | -$14.78 M(+24.7%) | -$36.75 M(+67.0%) |
Mar 2012 | - | -$11.85 M(+21.1%) | -$22.01 M(+116.6%) |
Dec 2011 | -$10.16 M(>+9900.0%) | -$9.78 M(+2830.5%) | -$10.16 M(+2654.1%) |
Sep 2011 | - | -$333.90 K(+873.5%) | -$368.80 K(+868.0%) |
Jun 2011 | - | -$34.30 K(+779.5%) | -$38.10 K(+514.5%) |
Mar 2011 | - | -$3900.00(-218.2%) | -$6200.00(-11.4%) |
Dec 2010 | -$7000.00(-58.3%) | $3300.00(-203.1%) | -$7000.00(-48.5%) |
Sep 2010 | - | -$3200.00(+33.3%) | -$13.60 K(-0.7%) |
Jun 2010 | - | -$2400.00(-48.9%) | -$13.70 K(-11.6%) |
Mar 2010 | - | -$4700.00(+42.4%) | -$15.50 K(-7.7%) |
Dec 2009 | -$16.80 K(+19.1%) | -$3300.00(0.0%) | -$16.80 K(+7.0%) |
Sep 2009 | - | -$3300.00(-21.4%) | -$15.70 K(-4.3%) |
Jun 2009 | - | -$4200.00(-30.0%) | -$16.40 K(+5.1%) |
Mar 2009 | - | -$6000.00(+172.7%) | -$15.60 K(+10.6%) |
Dec 2008 | -$14.10 K | -$2200.00(-45.0%) | -$14.10 K(+18.5%) |
Sep 2008 | - | -$4000.00(+17.6%) | -$11.90 K(+50.6%) |
Jun 2008 | - | -$3400.00(-24.4%) | -$7900.00(+75.6%) |
Mar 2008 | - | -$4500.00 | -$4500.00 |
FAQ
- What is Puma Biotechnology annual operating income?
- What is the all time high annual operating profit for Puma Biotechnology?
- What is Puma Biotechnology annual operating profit year-on-year change?
- What is Puma Biotechnology quarterly operating income?
- What is the all time high quarterly operating profit for Puma Biotechnology?
- What is Puma Biotechnology quarterly operating profit year-on-year change?
- What is Puma Biotechnology TTM operating income?
- What is the all time high TTM operating profit for Puma Biotechnology?
- What is Puma Biotechnology TTM operating profit year-on-year change?
What is Puma Biotechnology annual operating income?
The current annual operating profit of PBYI is $33.27 M
What is the all time high annual operating profit for Puma Biotechnology?
Puma Biotechnology all-time high annual operating income is $33.27 M
What is Puma Biotechnology annual operating profit year-on-year change?
Over the past year, PBYI annual operating income has changed by +$2.54 M (+8.28%)
What is Puma Biotechnology quarterly operating income?
The current quarterly operating profit of PBYI is $22.08 M
What is the all time high quarterly operating profit for Puma Biotechnology?
Puma Biotechnology all-time high quarterly operating income is $22.08 M
What is Puma Biotechnology quarterly operating profit year-on-year change?
Over the past year, PBYI quarterly operating income has changed by +$12.87 M (+139.73%)
What is Puma Biotechnology TTM operating income?
The current TTM operating profit of PBYI is $32.40 M
What is the all time high TTM operating profit for Puma Biotechnology?
Puma Biotechnology all-time high TTM operating income is $35.83 M
What is Puma Biotechnology TTM operating profit year-on-year change?
Over the past year, PBYI TTM operating income has changed by +$3.92 M (+13.75%)